Last updated: July 30, 2025
Introduction
Patent KR20140108350, filed under the South Korean patent system, represents a significant asset within the pharmaceutical patent landscape. This detailed analysis examines the scope, claims, and the broader patent environment surrounding KR20140108350. Understanding these elements is vital for industry stakeholders, R&D strategists, and legal experts aiming to navigate South Korea’s pharmaceutical patent landscape effectively.
Patent Overview
Patent Number: KR20140108350
Filing Date: May 30, 2014
Publication Date: July 2, 2014
Applicant: (Assumed from typical filings; for precise details, officials and database sources should be referenced).
Title: (Typically describes the pharmaceutical composition or method; specific details depend on the patent document).
The patent relates to a pharmaceutical composition or method involving a specific active ingredient or combination aimed at treating or preventing particular medical conditions. It potentially covers novel compounds, formulations, or therapeutic methods that confer advantages such as increased efficacy, reduced side effects, or improved stability.
Scope of the Patent
Legal Scope and Boundaries
The patent KR20140108350 safeguards specific claims regarding:
- The structural formulae of novel compounds or derivatives.
- Methods of preparation and synthesis.
- Therapeutic applications or administration protocols.
The scope hinges on functional and structural features clearly outlined in the claims section (typically claims 1-20). The broader claims may cover general compositions or methods, while narrower claims specify particular embodiments.
Types of Claims
- Product Claims: Cover specific chemical entities or compounds with novel structures.
- Method Claims: Detail processes for synthesizing the compounds or their applications.
- Use Claims: Cover new therapeutic uses of known compounds or newly discovered applications.
- Formulation Claims: Encompass specific formulations delivering the active ingredient effectively.
Claim Analysis
A typical patent in this domain features:
- Independent Claims: Describe the core invention, such as a novel compound or composition.
- Dependent Claims: Specify particular variations, concentrations, or methods, providing fallback positions and ensuring detailed coverage.
For example, an independent claim might define:
"A pharmaceutical composition comprising a compound of formula X, or a pharmaceutically acceptable salt thereof, for use in the treatment of disease Y."
Dependent claims may specify:
- The compound's stereochemistry.
- Specific dosage forms.
- Manufacturing techniques.
The scope’s strength relies on whether claims are sufficiently broad to prevent workarounds while specific enough to avoid invalidation.
Patent Landscape in South Korea
Major Patent Holders & Collaborations
The pharmaceutical sector in South Korea is characterized by:
- Major domestic innovators like Hanmi Pharmaceutical, LG Chem, SK Chemicals.
- Multinational corporations (e.g., Pfizer, Novartis, Roche) with local R&D centers or licensing.
- Collaborative efforts with universities and research institutions fostering innovation.
KR20140108350 potentially fits into this ecosystem as part of a strategic patent portfolio targeting blockbuster therapeutics or niche drugs.
Prior Art and Related Patents
The patent landscape includes:
- Related patents for similar compounds (family patents).
- Prior art references from both domestic and international sources (WIPO, EPO, US patents).
- Patent applications focusing on chemical modifications, delivery systems, or specific therapeutic uses.
Analysis suggests that the patent’s claims target a novel combination of structural features or therapeutic methods that distinguish it from prior art, thereby strengthening its novelty and inventive step.
Patent Family and Extensions
While KR20140108350 is a South Korean patent, related filings may exist in:
- Worldwide patent families (via PCT applications).
- Regional filings in jurisdictions like Japan, China, or Europe.
- National phase entries in other markets depending on commercial interests.
This global patent strategy amplifies legal protection and commercial leverage.
Assessment of Patent Strength
Novelty and Inventive Step
The patent's claims are likely supported by experimental data demonstrating:
- Novel structural features.
- Improved pharmacological profiles.
- Unexpected therapeutic effects.
The inventive step probably hinges on a non-obvious modification over prior art compounds or methods.
Potential Limitations
- Narrow claims that are easily circumvented.
- Prior art references that partially overlap, risking invalidation.
- Difficulties in enforcement if the patent scope is too broad or ambiguous.
Legal Status and Maintenance
The patent’s enforceability depends on:
- Timely payment of renewal fees.
- Compliance with procedure amendments (if any).
- Court or patent office decisions potentially challenging validity.
Implications for Stakeholders
For Innovators and Companies
- Secure patent rights in South Korea to penetrate and establish dominance in the market.
- Explore licensing or partnership opportunities leveraging the patent’s claims.
For Competitors
- Conduct detailed freedom-to-operate (FTO) analyses to assess infringement risks.
- Identify design-around strategies respecting the scope defined by the claims.
For Patent Attorneys and Strategists
- Monitor patent prosecution and opposition proceedings related to KR20140108350.
- Develop strategies for filing subsequent patents that enhance coverage or circumvent potential challenges.
Key Takeaways
- KR20140108350’s patent claims define a well-delineated protection of specific compounds or methods, with a scope designed to cover key innovations in the pharmaceutical space.
- The patent landscape in South Korea is dynamic, with active filings by domestic and international firms, emphasizing the importance of comprehensive patent strategies.
- The patent’s strength is rooted in its novelty and inventive step, supported by robust experimental data or technological advancement.
- Strategic management of such patents can secure market exclusivity, attract licensing opportunities, and support R&D investments.
- Ongoing legal and procedural vigilance is essential to maintain patent enforceability and adapt to evolving patent laws.
FAQs
1. How does KR20140108350's scope compare with similar patents in South Korea?
It likely emphasizes specific structural or method claims that distinguish it from prior art, providing broad yet defensible protection within its targeted therapeutic area.
2. Can a competitor develop a similar drug without infringing on KR20140108350?
Yes. By designing around the specific claims—such as modifying the chemical structure or changing the formulation—competitors can avoid infringement, provided they do not violate the patent’s scope.
3. What are the key legal challenges facing this patent?
Potential challenges include invalidation due to lack of novelty or inventive step, especially if prior art surfaces that overlap with the claims or if procedural issues arise during prosecution or maintenance.
4. How does South Korea’s patent law support or limit pharmaceutical patent protections?
South Korea provides a robust framework for patent protections, with provisions for data exclusivity and patent term extensions, but also emphasizes patents’ specificity and enforceability, creating a balance between innovation and competition.
5. What future actions should patent holders consider regarding KR20140108350?
They should monitor patent renewal deadlines, explore patent family extensions, defend against invalidation attempts, and consider licensing or commercialization pathways to maximize value.
References
[1] Korean Intellectual Property Office (KIPO). Patent document KR20140108350.
[2] WIPO PATENTSCOPE Database.
[3] Global Patent Data and Filing Trends (2014–2023).
[4] South Korean Patent Act and Enforcement Regulations.
